Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG). için istatistikler

Toplam ziyaret

views
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG). 0

Aylık toplam ziyaret

views
Nisan 2024 0
Mayıs 2024 0
Haziran 2024 0
Temmuz 2024 0
Ağustos 2024 0
Eylül 2024 0
Ekim 2024 0